Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of TAK-536 Pediatric Granules vs Tablet in Healthy Adult Males
jRCT1080223448Phase 1
- Sponsor
- Takeda
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azilsartan medoxomil in hypertension (HTN) (2 cohorts), sponsored by Takeda. Primary endpoint: Primary pharmacokinetic endpoints.
02
Drugs
azilsartan medoxomil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT1080223448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223448.